CF PHARMTECH (02652) spent approximately HK$385,300 on repurchasing 11,000 shares on February 5th.
Changfeng Pharmaceuticals (02652) announced that on February 5, 2026, it spent approximately HK$385,000 to repurchase 11,000 shares.
CF PHARMTECH (02652) announced on February 5, 2026, that it will repurchase 11,000 shares at a cost of approximately HKD 385,000.
Related Articles

PROSPEROUSPRINT (08385): Lai Ziyuan appointed as executive director.

GEEKPLUS-W(02590) achieved orders of 4.137 billion yuan in 2025, an increase of approximately 31.7% compared to the previous year.

CN INT DEV CORP (00264) has entered into a memorandum of supplementary agreement with Xu Xichang to extend the exclusivity period by 3 months.
PROSPEROUSPRINT (08385): Lai Ziyuan appointed as executive director.

GEEKPLUS-W(02590) achieved orders of 4.137 billion yuan in 2025, an increase of approximately 31.7% compared to the previous year.

CN INT DEV CORP (00264) has entered into a memorandum of supplementary agreement with Xu Xichang to extend the exclusivity period by 3 months.






